Christine C. Gana

Targeting Functional Activity of AKT Has Efficacy against Aggressive Neuroblastoma.

J. Fletcher, M. Kavallaris, M. Le Grand, 2020, ACS pharmacology & translational science.

MRP1 modulators synergize with buthionine sulfoximine to exploit collateral sensitivity and selectively kill MRP1-expressing cancer cells.

J. Fletcher, S. Cole, M. Haber, 2019, Biochemical pharmacology.